ENVB
Enveric Biosciences Inc
NASDAQ: ENVB · HEALTHCARE · BIOTECHNOLOGY
$3.95
-23.45% today
Updated 2026-04-30
Market cap
$10.01M
P/E ratio
—
P/S ratio
0.08x
EPS (TTM)
$-36.24
Dividend yield
—
52W range
$2 – $18
Volume
5.0M
Enveric Biosciences Inc (ENVB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $333201.00 | $750706.00 | — | — | — | — | — | — | — | $15.98M | $36.15M | $48.59M | $43.00M | $39.91M | $39.91M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +125.3% | -100.0% | — | — | — | — | — | — | — | +126.2% | +34.4% | -11.5% | -7.2% | +0.0% | -100.0% | — | — | — | — |
| Cost of revenue | $897.00 | $63269.00 | — | — | — | $31395.00 | $22690.00 | — | — | $10.23M | $29.61M | $38.36M | $34.01M | $31.76M | $120872.00 | $681612.00 | $435201.00 | $408030.00 | $337489.00 | $200858.00 |
| Gross profit | $332304.00 | $687437.00 | — | — | — | $-31395.00 | $-22690.00 | — | — | $5.75M | $6.54M | $10.24M | $8.98M | $8.15M | $-120872.00 | $-681612.00 | $-435201.00 | $-408030.00 | $-337489.00 | $-200858.00 |
| Gross margin | 99.7% | 91.6% | — | — | — | — | — | — | — | 36.0% | 18.1% | 21.1% | 20.9% | 20.4% | -0.3% | — | — | — | — | — |
| R&D | $157739.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | $174083.00 | $4.79M | $8.03M | $7.25M | $2.84M | $2.78M |
| SG&A | — | $433667.00 | — | — | $35875.00 | $31395.00 | $22690.00 | $27211.00 | $32811.00 | $5.69M | $8.55M | $18.51M | $10.79M | $2.30M | $5.44M | $20.50M | $11.61M | $8.85M | $6.45M | $5.79M |
| Operating income | $-353541.00 | $253770.00 | $-151441.00 | $-55569.00 | $-35875.00 | $-31395.00 | $-22690.00 | $-27211.00 | $-32811.00 | $-1.87M | $-5.38M | $-11.97M | $-7.15M | $-6.32M | $-5.62M | $-25.94M | $-19.96M | $-16.45M | $-9.63M | $-8.77M |
| Operating margin | -106.1% | 33.8% | — | — | — | — | — | — | — | -11.7% | -14.9% | -24.6% | -16.6% | -15.8% | -14.1% | — | — | — | — | — |
| EBITDA | $-308332.00 | $-210350.00 | $-151441.00 | $-55569.00 | $-35875.00 | $-31395.00 | $-22690.00 | $-27211.00 | $-32811.00 | $-537780.00 | $-4.41M | $-7.67M | $-6.92M | $-2.26M | $-6.30M | $-55.74M | $-19.52M | $-16.85M | $-9.23M | $-8.57M |
| EBITDA margin | -92.5% | -28.0% | — | — | — | — | — | — | — | -3.4% | -12.2% | -15.8% | -16.1% | -5.7% | -15.8% | — | — | — | — | — |
| EBIT | $-345561.00 | $304727.00 | $-151441.00 | $-55569.00 | $-35875.00 | $-31395.00 | $-22690.00 | $-27211.00 | $-32811.00 | $-695721.00 | $-5.77M | $-10.89M | $-9.82M | $-4.52M | $-6.42M | $-56.42M | $-19.95M | $-17.26M | $-9.57M | $-8.77M |
| Interest expense | $2266.00 | $553506.00 | $12648.00 | $0.00 | $0.00 | $0.00 | $0.00 | $28500.00 | $0.00 | $238471.00 | $751074.00 | $575039.00 | $729896.00 | $691138.00 | $445250.00 | $10316.00 | $5249.00 | $3708.00 | — | $106.00 |
| Income tax | $4800.00 | $-553506.00 | $4843.00 | $2975.00 | $3566.00 | $1985.00 | $1931.00 | $1450.00 | $833.00 | $-128460.00 | $-3.75M | $-2.39M | $6.35M | $388657.00 | $-477731.00 | $-7.45M | $-1.49M | $28913.00 | $8930.00 | — |
| Effective tax rate | -1.4% | -218.1% | -3.5% | -5.4% | -9.9% | -6.3% | -8.5% | 112.5% | -2.5% | 6.4% | 57.4% | 20.9% | -60.2% | -7.5% | 6.5% | 13.2% | 7.4% | 248.8% | -0.1% | 0.0% |
| Net income | $-352626.00 | $807276.00 | $-143636.00 | $-58544.00 | $-39441.00 | $-33380.00 | $-24621.00 | $-161.00 | $-33644.00 | $-1.89M | $-2.78M | $-9.07M | $-16.90M | $-5.60M | $-6.86M | $-48.98M | $-18.50M | $-17291.00 | $-9.57M | $-12.13M |
| Net income growth (YoY) | — | +328.9% | -117.8% | +59.2% | +32.6% | +15.4% | +26.2% | +99.3% | -20796.9% | -5519.9% | -47.1% | -226.4% | -86.2% | +66.8% | -22.5% | -613.5% | +62.2% | +99.9% | -55275.6% | -26.7% |
| Profit margin | -105.8% | 107.5% | — | — | — | — | — | — | — | -11.8% | -7.7% | -18.7% | -39.3% | -14.0% | -17.2% | — | — | — | — | — |